Baggio, Laurie L.
Varin, Elodie M. http://orcid.org/0000-0003-1514-2362
Koehler, Jacqueline A.
Cao, Xiemin
Lokhnygina, Yuliya
Stevens, Susanna R.
Holman, Rury R. http://orcid.org/0000-0002-1256-874X
Drucker, Daniel J. http://orcid.org/0000-0001-6688-8127
Article History
Received: 27 October 2019
Accepted: 7 July 2020
First Online: 28 July 2020
Competing interests
: This study was supported in part by a grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. Dr. Drucker has served as an advisor or consultant or speaker within the past 12 months to Forkhead Biotherapeutics, Intarcia Therapeutics, Merck & Co., Novo Nordisk Inc. and Sanofi Inc. Neither Dr. Drucker nor his family members hold stock directly or indirectly in any of these companies. Dr. Holman reports receiving grants from AstraZeneca and grants and personal fees from Bayer, Boehringer Ingelheim and Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, personal fees from Novartis, Amgen and Servier, and financial support from Elcelyx, GlaxoSmithKline, Janssen and Takeda outside the submitted work. All other authors declare no competing interests.